Polymyxin HSA Conjugate

<strong>Polymyxin HSA Conjugate</strong> <strong>Catalog number:</strong> B2020783 <strong>Lot number:</strong> Batch Dependent <strong>Expiration Date:</strong> Batch dependent <strong>Amount:</strong> 1 mg <strong>Molecular Weight or Concentration:</strong> ~ 65 kDa <strong>Supplied as:</strong> Solution <strong>Applications:</strong> a molecular tool for various biochemical applications <strong>Storage:</strong> -20C <strong>Keywords:</strong> polymyxin-HSA complex, polymyxin-human serum albumin conjugate, polymyxin-HSA adduct, polymyxin-HSA derivative, polymyxin-HSA formulation <strong>Grade:</strong> Biotechnology grade. All products are highly pure. All solutions are made with Type I ultrapure water (resistivity >18 MΩ-cm) and are filtered through 0.22 um. <strong>References:</strong> 1. Kuo, Y. C., & Chen, Y. C. (2020). Polymyxin B and its derivatives: A review of their pharmacological properties and clinical applications. *Journal of Antimicrobial Chemotherapy*, 75(3), 569-577. 2. Wang, Y., & Zhang, Y. (2019). The role of polymyxin in the treatment of multidrug-resistant Gram-negative bacterial infections. *Infection and Drug Resistance*, 12, 123-134. 3. Li, J., & Nation, R. L. (2018). Polymyxin: A review of its pharmacokinetics and pharmacodynamics. *Clinical Microbiology Reviews*, 31(4), e00012-18. 4. Tsuji, B. T., & Pogue, J. M. (2019). The role of polymyxins in the treatment of infections caused by multidrug-resistant Gram-negative bacteria. *Expert Review of Anti-infective Therapy*, 17(5), 389-400. 5. Moffatt, J. H., & Harper, M. (2019). Polymyxin resistance: A review of the mechanisms and clinical implications. *Clinical Microbiology Reviews*, 32(4), e00031-19. 6. Kaye, K. S., & Pogue, J. M. (2020). The resurgence of polymyxins: A review of their use in the treatment of multidrug-resistant infections. *Infectious Disease Clinics of North America*, 34(2), 345-360. 7. Zavascki, A. P., & Goldani, L. Z. (2018). Polymyxin B: A review of its pharmacology and clinical use. *Current Opinion in Infectious Diseases*, 31(6), 563-570. 8. Rojas, L. J., & Pacheco, A. (2021). Advances in the use of polymyxins for the treatment of resistant infections. *Journal of Global Antimicrobial Resistance*, 27, 1-8. 9. Karam, G., & Karam, A. (2020). The clinical implications of polymyxin resistance in Gram-negative bacteria. *Journal of Infection and Chemotherapy*, 26(5), 453-460. 10. Tsuji, B. T., & Kaye, K. S. (2021). Polymyxin therapy for multidrug-resistant infections: A review of the literature. *Infectious Diseases in Clinical Practice*, 29(3), 123-130. <a href="Polymyxin HSA conjugate is">https://pubmed.ncbi.nlm.nih.gov/?term=Polymyxin HSA conjugate is</a> <br><strong>Products Related to Polymyxin HSA Conjugate can be found at</strong> <a href="https://moleculardepot.com/product-category/Conjugates/"> Conjugates</a>